The volume profile levels are a good measurement of where the action will be (peaks and valleys). We can see the price moving upwards with the news of their recently awarded patent, and the bioequivalence study coming in 21Q1.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.